{"nct_id":"NCT00035334","title":"Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis","status":"COMPLETED","status_verified_date":"2006-02","start_date":"2001-10","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2004-12","completion_date_type":null,"phases":["PHASE2","PHASE3"],"tickers":["GSK"]}